Search

everythinglearnresearchcommunity

for

Search:↓

Certain proteins and their receptors are more active during the growth phase of human hair and could be targeted to treat hair disorders.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

HPV genes and estradiol increase a cancer-related signaling pathway, which may be targeted for cervical cancer treatment.

The document concludes that better understanding the wound microbiome can improve chronic wound care by preserving helpful bacteria and targeting harmful ones.

High leptin levels may promote skin cancer and inflammation, suggesting potential for leptin-targeted therapies.

mTORC1 activity is important for hair growth and color, and targeting it could help treat hair loss and greying.

IGF2BP3 gene is up-regulated in keloid patients, suggesting potential targets for treatment.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

β-Catenin signaling is involved in brain cell growth after injury and could be a therapy target.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

Platelet-rich plasma is as effective as mineral trioxide aggregate for pulp capping and may offer better cellular responses.

FGF-5 promotes Cashmere goat hair growth by increasing keratin genes and reducing certain LncRNA and target genes.

Shi-Bi-Man activates hair follicle stem cells and promotes hair growth by changing lactic acid metabolism and other cellular processes.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Scarring alopecia affects different hair follicle stem cells than nonscarring alopecia, and the infundibular region could be a new treatment target.

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Ketogenic diet, neurosteroids, and HMGB1-TLR4 signaling pathway are potential targets for new epilepsy treatments.

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

Hair gets thinner, grayer, and changes texture with age due to genetics, environment, and cellular changes, affecting the growth cycle.

A protein called ectodysplasin-A2 increases a hair growth inhibitor in balding cells, which could be a target for hair loss treatment.